These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26096869)

  • 21. Chemometric evaluation of near infrared, fourier transform infrared, and Raman spectroscopic models for the prediction of nimodipine polymorphs.
    Siddiqui A; Rahman Z; Sayeed VA; Khan MA
    J Pharm Sci; 2013 Nov; 102(11):4024-35. PubMed ID: 23963767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A headspace-gas chromatography method for isopropanol determination in warfarin sodium products as a measure of drug crystallinity.
    Rahman Z; Akhtar S; Siddiqui A; Ciavarella AB; Nguyenpho A; Faustino PJ; Khan MA
    Acta Pharm; 2018 Mar; 68(1):31-46. PubMed ID: 29453909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid-state characterization of amorphous and mesomorphous calcium ketoprofen.
    Atassi F; Mao C; Masadeh AS; Byrn SR
    J Pharm Sci; 2010 Sep; 99(9):3684-97. PubMed ID: 19780126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the microcrystallinity of a drug substance, indomethacin, in a pharmaceutical model tablet by chemometric FT-Raman spectroscopy.
    Okumura T; Otsuka M
    Pharm Res; 2005 Aug; 22(8):1350-7. PubMed ID: 16078145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the crystallinity of cephalexin in pharmaceutical formulations by chemometrical near-infrared spectroscopy.
    Fukui Y; Otsuka M
    Drug Dev Ind Pharm; 2010 Jan; 36(1):72-80. PubMed ID: 19656006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an analytical method for crystalline content determination in amorphous solid dispersions produced by hot-melt extrusion using transmission Raman spectroscopy: A feasibility study.
    Netchacovitch L; Dumont E; Cailletaud J; Thiry J; De Bleye C; Sacré PY; Boiret M; Evrard B; Hubert P; Ziemons E
    Int J Pharm; 2017 Sep; 530(1-2):249-255. PubMed ID: 28746834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of amorphous content in the pharmaceutical process environment.
    Savolainen M; Jouppila K; Pajamo O; Christiansen L; Strachan C; Karjalainen M; Rantanen J
    J Pharm Pharmacol; 2007 Feb; 59(2):161-70. PubMed ID: 17270070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of In-Use Stability of Anticoagulant Drug Products: Warfarin Sodium.
    Nguyenpho A; Ciavarella AB; Siddiqui A; Rahman Z; Akhtar S; Hunt R; Korang-Yeboah M; Khan MA
    J Pharm Sci; 2015 Dec; 104(12):4232-4240. PubMed ID: 26501849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a nonribosomal peptide antibiotic solid dispersion formulation by process analytical technologies sensors.
    Rahman Z; Siddiqui A; Khan MA
    J Pharm Sci; 2013 Dec; 102(12):4337-46. PubMed ID: 24114944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137--a successful approach.
    Petzoldt C; Bley O; Byard SJ; Andert D; Baumgartner B; Nagel N; Tappertzhofen C; Feth MP
    Eur J Pharm Biopharm; 2014 Apr; 86(3):337-50. PubMed ID: 24075979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitation of trace amorphous solifenacin succinate in pharmaceutical formulations by transmission Raman spectroscopy.
    Terada H; Hattori Y; Sasaki T; Otsuka M
    Int J Pharm; 2019 Jun; 565():325-332. PubMed ID: 31075440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of casein phosphorylation with conformational interpretation using Raman spectroscopy.
    Jarvis RM; Blanch EW; Golovanov AP; Screen J; Goodacre R
    Analyst; 2007 Oct; 132(10):1053-60. PubMed ID: 17893810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the crystalline and amorphous states of drug products by nanothermal analysis and Raman imaging.
    Nakamoto K; Urasaki T; Hondo S; Murahashi N; Yonemochi E; Terada K
    J Pharm Biomed Anal; 2013 Mar; 75():105-11. PubMed ID: 23246930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Warfarin Sodium Stability in Oral Formulations.
    Dimitrokalli E; Fertaki S; Lykouras M; Kokkinos P; Orkoula M; Kontoyannis C
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raman spectroscopy for the qualitative and quantitative analysis of solid dosage forms of Sitagliptin.
    Bakkar MA; Nawaz H; Majeed MI; Naseem A; Ditta A; Rashid N; Ali S; Bajwa J; Bashir S; Ahmad S; Hyat H; Bukhari KS; Bonnier F
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Jan; 245():118900. PubMed ID: 32920444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical stability and recrystallization kinetics of amorphous ibipinabant drug product by fourier transform raman spectroscopy.
    Sinclair W; Leane M; Clarke G; Dennis A; Tobyn M; Timmins P
    J Pharm Sci; 2011 Nov; 100(11):4687-99. PubMed ID: 21681752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two solid forms of tauroursodeoxycholic acid and the effects of milling and storage temperature on solid-state transformations.
    Xu K; Zheng S; Zhai Y; Guo L; Tang P; Yan J; Wu D; Li H
    Int J Pharm; 2015; 486(1-2):185-94. PubMed ID: 25841565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of different chemometric methods to extract chemical and physical information from Raman images of homogeneous and heterogeneous semi-solid pharmaceutical formulations.
    Mitsutake H; Castro SR; de Paula E; Poppi RJ; Rutledge DN; Breitkreitz MC
    Int J Pharm; 2018 Dec; 552(1-2):119-129. PubMed ID: 30266516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of partial least-squares (PLS) modeling in quantifying drug crystallinity in amorphous solid dispersions.
    Rumondor AC; Taylor LS
    Int J Pharm; 2010 Oct; 398(1-2):155-60. PubMed ID: 20678562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative determination of solid-state forms of a pharmaceutical development compound in drug substance and tablets.
    Xie Y; Tao W; Morrison H; Chiu R; Jona J; Fang J; Cauchon N
    Int J Pharm; 2008 Oct; 362(1-2):29-36. PubMed ID: 18588963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.